WO1999065469A3 - Processes to generate submicron particles of water-insoluble compounds - Google Patents
Processes to generate submicron particles of water-insoluble compounds Download PDFInfo
- Publication number
- WO1999065469A3 WO1999065469A3 PCT/US1999/013755 US9913755W WO9965469A3 WO 1999065469 A3 WO1999065469 A3 WO 1999065469A3 US 9913755 W US9913755 W US 9913755W WO 9965469 A3 WO9965469 A3 WO 9965469A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- submicron particles
- insoluble compounds
- processes
- generate submicron
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/50—Mixing liquids with solids
- B01F23/51—Methods thereof
- B01F23/511—Methods thereof characterised by the composition of the liquids or solids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/20—Jet mixers, i.e. mixers using high-speed fluid streams
- B01F25/28—Jet mixers, i.e. mixers using high-speed fluid streams characterised by the specific design of the jet injector
- B01F25/281—Jet mixers, i.e. mixers using high-speed fluid streams characterised by the specific design of the jet injector the jet injector being of the explosive rapid expansion of supercritical solutions [RESS] or fluid injection of molecular spray [FIMS] type, i.e. the liquid is jetted in an environment (gas or liquid) by nozzles, in conditions of significant pressure drop, with the possible generation of shock waves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J3/00—Processes of utilising sub-atmospheric or super-atmospheric pressure to effect chemical or physical change of matter; Apparatus therefor
- B01J3/008—Processes carried out under supercritical conditions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
- B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/04—Specific aggregation state of one or more of the phases to be mixed
- B01F23/043—Mixing fluids or with fluids in a supercritical state, in supercritical conditions or variable density fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/50—Mixing liquids with solids
- B01F23/56—Mixing liquids with solids by introducing solids in liquids, e.g. dispersing or dissolving
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/797—Lipid particle
- Y10S977/798—Lipid particle having internalized material
- Y10S977/799—Containing biological material
- Y10S977/801—Drug
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU46938/99A AU755993C (en) | 1998-06-19 | 1999-06-18 | Processes to generate submicron particles of water-insoluble compounds |
AT99930387T ATE233549T1 (en) | 1998-06-19 | 1999-06-18 | NEW PROCESS FOR PRODUCING PARTICLES OF WATER-INSOLUBLE COMPONENTS IN THE SIZE RANGE UP TO 2000 NM |
CA002335472A CA2335472C (en) | 1998-06-19 | 1999-06-18 | Processes to generate submicron particles of water-insoluble compounds |
EP99930387A EP1089714B1 (en) | 1998-06-19 | 1999-06-18 | Processes to generate particles of water-insoluble compounds of up to 2000 nm in size |
IL14027699A IL140276A0 (en) | 1998-06-19 | 1999-06-18 | Processes to generate submicron particles of water-insoluble compounds |
DE69905716T DE69905716T2 (en) | 1998-06-19 | 1999-06-18 | NEW PROCESS FOR PRODUCING PARTICLES OF WATER-INSOLUBLE COMPONENTS IN THE SIZE RANGE UP TO 2000 NM |
JP2000554349A JP4693238B2 (en) | 1998-06-19 | 1999-06-18 | Method for producing submicron particles of water insoluble compounds |
IL140276A IL140276A (en) | 1998-06-19 | 2000-12-13 | Processes to generate suspensions of water-insoluble biologically active compounds containing particles of sizes of up to two microns |
SE0004620A SE521255C2 (en) | 1998-06-19 | 2000-12-14 | Process for the preparation of submicron particles of water-insoluble compounds |
HK02100959.7A HK1039566A1 (en) | 1998-06-19 | 2002-02-07 | Process to generate submicron particles of water-insoluble compounds |
AU2003203459A AU2003203459A1 (en) | 1998-06-19 | 2003-04-01 | Processes to generate submicron particles of water-insoluble compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8985298P | 1998-06-19 | 1998-06-19 | |
US60/089,852 | 1998-06-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999065469A2 WO1999065469A2 (en) | 1999-12-23 |
WO1999065469A3 true WO1999065469A3 (en) | 2000-03-02 |
Family
ID=22219900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/013755 WO1999065469A2 (en) | 1998-06-19 | 1999-06-18 | Processes to generate submicron particles of water-insoluble compounds |
Country Status (14)
Country | Link |
---|---|
US (1) | US6177103B1 (en) |
EP (1) | EP1089714B1 (en) |
JP (2) | JP4693238B2 (en) |
KR (1) | KR100622047B1 (en) |
CN (1) | CN1160059C (en) |
AT (1) | ATE233549T1 (en) |
AU (2) | AU755993C (en) |
CA (1) | CA2335472C (en) |
DE (1) | DE69905716T2 (en) |
ES (1) | ES2194477T3 (en) |
HK (1) | HK1039566A1 (en) |
IL (2) | IL140276A0 (en) |
SE (1) | SE521255C2 (en) |
WO (1) | WO1999065469A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835396B2 (en) | 2001-09-26 | 2004-12-28 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion lyophilization |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US8722091B2 (en) | 2001-09-26 | 2014-05-13 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion lyophilization |
Families Citing this family (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2234957C (en) * | 1995-10-17 | 2006-12-19 | Inge B. Henriksen | Insoluble drug delivery |
US6465016B2 (en) * | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
GB9703673D0 (en) * | 1997-02-21 | 1997-04-09 | Bradford Particle Design Ltd | Method and apparatus for the formation of particles |
US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
WO2000018374A1 (en) * | 1998-10-01 | 2000-04-06 | Elan Pharma International, Ltd. | Controlled release nanoparticulate compositions |
US20080213378A1 (en) * | 1998-10-01 | 2008-09-04 | Elan Pharma International, Ltd. | Nanoparticulate statin formulations and novel statin combinations |
US20040013613A1 (en) * | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
US8236352B2 (en) * | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
US20040141925A1 (en) * | 1998-11-12 | 2004-07-22 | Elan Pharma International Ltd. | Novel triamcinolone compositions |
US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
US20040115134A1 (en) * | 1999-06-22 | 2004-06-17 | Elan Pharma International Ltd. | Novel nifedipine compositions |
US20090104273A1 (en) * | 1999-06-22 | 2009-04-23 | Elan Pharma International Ltd. | Novel nifedipine compositions |
WO2001024917A1 (en) * | 1999-10-07 | 2001-04-12 | Battelle Memorial Institute | Method and apparatus for obtaining a suspension of particles |
US6761909B1 (en) * | 1999-12-21 | 2004-07-13 | Rxkinetix, Inc. | Particulate insulin-containing products and method of manufacture |
WO2001045731A1 (en) * | 1999-12-21 | 2001-06-28 | Rxkinetix, Inc. | Particulate drug-containing products and method of manufacture |
AU4724401A (en) * | 2000-02-28 | 2001-09-12 | Genesegues Inc | Nanocapsule encapsulation system and method |
WO2001066091A1 (en) * | 2000-03-09 | 2001-09-13 | Astrazeneca Ab | Method of preparing solid dispersions |
US20040156872A1 (en) * | 2000-05-18 | 2004-08-12 | Elan Pharma International Ltd. | Novel nimesulide compositions |
MY120279A (en) | 2000-05-26 | 2005-09-30 | Pharmacia Corp | Use of a celecoxib composition for fast pain relief |
US20030224058A1 (en) * | 2002-05-24 | 2003-12-04 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
US7276249B2 (en) * | 2002-05-24 | 2007-10-02 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
US20080241070A1 (en) * | 2000-09-21 | 2008-10-02 | Elan Pharma International Ltd. | Fenofibrate dosage forms |
US7198795B2 (en) * | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
US6541542B2 (en) * | 2000-09-29 | 2003-04-01 | Eastman Chemical Company | Process for production of polymeric powders |
US7193084B2 (en) * | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
US7037528B2 (en) * | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US20030096013A1 (en) * | 2000-12-22 | 2003-05-22 | Jane Werling | Preparation of submicron sized particles with polymorph control |
EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
US7276184B2 (en) * | 2001-07-12 | 2007-10-02 | Eastman Kodak Company | Surfactant assisted nanomaterial generation process |
GB0119480D0 (en) | 2001-08-09 | 2001-10-03 | Jagotec Ag | Novel compositions |
JP2005508939A (en) * | 2001-10-12 | 2005-04-07 | エラン ファーマ インターナショナル,リミティド | Composition having combined immediate release and sustained release characteristics |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
US20040101566A1 (en) * | 2002-02-04 | 2004-05-27 | Elan Pharma International Limited | Novel benzoyl peroxide compositions |
CA2475092C (en) * | 2002-02-04 | 2012-05-01 | Christian F. Wertz | Nanoparticulate compositions having lysozyme as a surface stabilizer |
US7186796B2 (en) | 2002-02-25 | 2007-03-06 | Phasex Corporation | Method for drying water-borne materials |
CA2479665C (en) * | 2002-03-20 | 2011-08-30 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
US20080220075A1 (en) * | 2002-03-20 | 2008-09-11 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
US20040038303A1 (en) * | 2002-04-08 | 2004-02-26 | Unger Gretchen M. | Biologic modulations with nanoparticles |
FR2838356B1 (en) * | 2002-04-15 | 2004-05-28 | Separex Sa | PROCESS FOR OBTAINING A STABLE SUSPENSION OF PARTICLES IN A LIQUID |
WO2003088951A1 (en) * | 2002-04-15 | 2003-10-30 | Eiffel Technologies Limited | Formulation of fine particles using liquefied or dense gases |
US20070264348A1 (en) * | 2002-05-24 | 2007-11-15 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
EP1531799A1 (en) * | 2002-06-10 | 2005-05-25 | Elan Pharma International Limited | Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions |
US20040258757A1 (en) * | 2002-07-16 | 2004-12-23 | Elan Pharma International, Ltd. | Liquid dosage compositions of stable nanoparticulate active agents |
UY27939A1 (en) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | COMPOUNDS |
ATE411010T1 (en) | 2002-12-13 | 2008-10-15 | Jagotec Ag | TOPICAL NANOPARTICLE SPIRONOLACTONE FORMULATION |
GB0229714D0 (en) * | 2002-12-20 | 2003-01-29 | Glaxo Group Ltd | Novel apparatus and method |
EP1652515A1 (en) * | 2003-08-06 | 2006-05-03 | Eisai Co., Ltd. | Process for producing drug ultramicroparticle and apparatus therefor |
WO2005053851A1 (en) * | 2003-11-26 | 2005-06-16 | E.I. Dupont De Nemours And Company | High pressure media milling system and process of milling particles |
US7582275B1 (en) | 2004-01-26 | 2009-09-01 | The United States Of America As Represented By The Secretary Of The Air Force | Method of processing filamentary nanocarbon |
US20050170063A1 (en) * | 2004-01-29 | 2005-08-04 | Lalit Chordia | Production of powder and viscous material |
EP1711163A2 (en) * | 2004-02-05 | 2006-10-18 | Baxter International Inc. | Dispersions prepared by use of self-stabilizing agents |
GB0406515D0 (en) * | 2004-03-23 | 2004-04-28 | Novartis Ag | Organic compounds |
WO2005089718A2 (en) * | 2004-03-23 | 2005-09-29 | Novartis Ag | Pharmaceutical compositions |
EP1730516A1 (en) * | 2004-03-30 | 2006-12-13 | Pfizer Products Incorporated | Method and device for evaluation of pharmaceutical compositions |
PL1731138T3 (en) * | 2004-03-31 | 2016-10-31 | Fine dispersion of sparingly soluble drug and process for producing the same | |
US7754243B2 (en) * | 2004-08-03 | 2010-07-13 | Clemson University Research Foundation | Aqueous suspension of nanoscale drug particles from supercritical fluid processing |
WO2006065725A1 (en) * | 2004-12-13 | 2006-06-22 | Cool Clean Technologies, Inc. | Carbon dioxide snow apparatus |
ES2265262B1 (en) * | 2005-01-31 | 2008-03-01 | Activery Biotech, S.L.(Titular Al 50%) | PROCEDURE FOR OBTAINING MICRO- AND NANODISPERSE SYSTEMS. |
RU2409352C2 (en) * | 2005-05-05 | 2011-01-20 | САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи | Stable compositions of nanoparticles |
BRPI0612071A2 (en) * | 2005-06-14 | 2010-10-19 | Baxter Int | pharmaceutical formulations to minimize drug interactions |
US20060280787A1 (en) * | 2005-06-14 | 2006-12-14 | Baxter International Inc. | Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof |
JP2007007524A (en) * | 2005-06-29 | 2007-01-18 | Kagawa Industry Support Foundation | Method and apparatus for preparing mono-dispersed ultrafine particles by rapidly cooling supercritical solution |
WO2007009986A2 (en) * | 2005-07-19 | 2007-01-25 | Activery Biotech, S.L. | Process for obtaining a composite |
ES2292300B1 (en) * | 2005-07-19 | 2009-02-16 | Sociedad Española De Carburos Metalicos, S.A.(Titular Al 50%) | PROCEDURE FOR OBTAINING A COMPOSITE MATERIAL. |
US7608461B1 (en) * | 2005-09-16 | 2009-10-27 | Sandia Corporation | Surface engineered nanoparticles for improved surface enhanced Raman scattering applications and method for preparing same |
DE102005053862A1 (en) * | 2005-11-04 | 2007-05-10 | Pharmasol Gmbh | Method and device for producing very fine particles and for coating such particles |
CA2628630A1 (en) * | 2005-11-15 | 2007-05-24 | Baxter International Inc. | Compositions of lipoxygenase inhibitors |
CN101331218B (en) * | 2005-12-16 | 2013-04-24 | 荷兰联合利华有限公司 | Surface-active material and its application |
AU2007265452A1 (en) * | 2006-06-26 | 2008-01-03 | Mutual Pharmaceutical Company, Inc. | Active agent formulations, methods of making, and methods of use |
MX2009003807A (en) * | 2006-10-17 | 2009-04-22 | Unilever Nv | Food composition comprising gas bubbles and process for preparing it. |
ZA200901780B (en) * | 2006-10-17 | 2010-06-30 | Unilever Plc | Food composition comprising gas bubbles and process for preparing it |
EP2081443A1 (en) * | 2006-10-17 | 2009-07-29 | Unilever N.V. | Aerated food product and process for preparing it |
US20100186420A1 (en) * | 2006-10-17 | 2010-07-29 | Mark John Berry | Frozen aerated food product comprising surface-active fibres |
AU2007312499B2 (en) * | 2006-10-17 | 2011-09-15 | Unilever Plc | Food composition comprising gas bubbles and process for preparing it |
CN1946120B (en) * | 2006-10-20 | 2010-05-12 | 华为技术有限公司 | Method and system for realizing telephone list association |
US20100062073A1 (en) * | 2006-11-29 | 2010-03-11 | Ronald Arthur Beyerinck | Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein |
JP5004333B2 (en) * | 2006-12-08 | 2012-08-22 | 日機装株式会社 | Nano-order particle manufacturing equipment |
US20090152176A1 (en) * | 2006-12-23 | 2009-06-18 | Baxter International Inc. | Magnetic separation of fine particles from compositions |
TWI405590B (en) | 2007-04-06 | 2013-08-21 | Activus Pharma Co Ltd | Method of producing pulverized organic compound particle |
US20100119612A1 (en) * | 2007-04-17 | 2010-05-13 | Bend Research, Inc | Nanoparticles comprising non-crystalline drug |
US20100080852A1 (en) * | 2007-05-03 | 2010-04-01 | Ronald Arthur Beyerinck | Phamaceutical composition comprising nanoparticles and casein |
WO2008135828A2 (en) * | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
WO2008135855A2 (en) * | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer |
US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
US8722736B2 (en) * | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
US8426467B2 (en) * | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US8974827B2 (en) * | 2007-06-04 | 2015-03-10 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
US9545384B2 (en) | 2007-06-04 | 2017-01-17 | Bend Research, Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate |
US20100215747A1 (en) * | 2007-07-13 | 2010-08-26 | Corey Jay Bloom | Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
JP5307382B2 (en) * | 2007-11-14 | 2013-10-02 | 日機装株式会社 | How to make fine particles |
WO2009073215A1 (en) * | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
US9233078B2 (en) * | 2007-12-06 | 2016-01-12 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer |
US20100159010A1 (en) * | 2008-12-24 | 2010-06-24 | Mutual Pharmaceutical Company, Inc. | Active Agent Formulations, Methods of Making, and Methods of Use |
US7828996B1 (en) | 2009-03-27 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Method for the manufacture of stable, nano-sized particles |
KR20120034649A (en) | 2009-05-11 | 2012-04-12 | 버그 바이오시스템즈, 엘엘씨 | Methods for treatment of disease using an epimetabolic shifter (coenzyme q10) |
US20100294986A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Supercritical fluid facilitated particle formation in microfluidic systems |
US20100298602A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Systems and methods for microfluidic crystallization |
NZ602057A (en) | 2010-03-12 | 2015-06-26 | Berg Pharma Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
PL2550092T3 (en) | 2010-03-22 | 2019-01-31 | Instillo Gmbh | Process for the production of micro- or nanoparticles |
ES2762451T3 (en) | 2011-04-04 | 2020-05-25 | Berg Llc | Treatment of tumors of the central nervous system with coenzyme Q10 |
SG10201605008TA (en) | 2011-06-17 | 2016-07-28 | Berg Llc | Inhalable pharmaceutical compositions |
EP2766018A4 (en) * | 2011-10-13 | 2015-02-25 | Univ Case Western Reserve | Rxr agonists compounds and methods |
US20150182542A1 (en) | 2012-02-16 | 2015-07-02 | Brightside Innovations, Inc. | Dietary and nutritional compositions and methods of use |
DK2978515T3 (en) | 2013-03-28 | 2019-04-08 | Instillo Gmbh | Device and method for preparing dispersions and solids |
EA032775B1 (en) | 2013-04-08 | 2019-07-31 | Берг Ллк | Methofs of treating cancer using coenzyme q10 combination therapies |
JP6595478B2 (en) | 2013-09-04 | 2019-10-23 | バーグ エルエルシー | Cancer treatment by continuous injection of coenzyme Q10 |
SG10201902499VA (en) | 2014-09-03 | 2019-04-29 | Genesegues Inc | Therapeutic nanoparticles and related compositions, methods and systems |
FI20140266A (en) | 2014-10-06 | 2016-04-07 | Nanoform Finland Oy | Method and apparatus for preparing nanoparticles |
CN110115952B (en) * | 2018-02-05 | 2021-10-15 | 绍兴吉能纳米科技有限公司 | High-pressure homogenizing method capable of using low-temperature liquefied gas |
JP2022533463A (en) | 2019-05-23 | 2022-07-22 | ヘルム・アクチエンゲゼルシャフト | Nanoparticles containing enzalutamide |
WO2021075003A1 (en) * | 2019-10-16 | 2021-04-22 | 株式会社 ナノ・キューブ・ジャパン | Method for manufacturing dispersion of ultrafine particles of poorly soluble substance |
EP3884930A1 (en) | 2020-03-23 | 2021-09-29 | Bayer AG | Nano-dry-melting |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3998753A (en) * | 1974-08-13 | 1976-12-21 | Hoffmann-La Roche Inc. | Water dispersible carotenoid preparations and processes thereof |
WO1995021688A1 (en) * | 1994-02-15 | 1995-08-17 | Eckhard Weidner | Process for preparing particles or powders |
WO1997014407A1 (en) * | 1995-10-17 | 1997-04-24 | Research Triangle Pharmaceuticals | Insoluble drug delivery |
WO1999052504A1 (en) * | 1998-04-09 | 1999-10-21 | F. Hoffmann-La Roche Ag | Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007414A1 (en) * | 1996-08-22 | 1998-02-26 | Research Triangle Pharmaceuticals Ltd. | Compositions comprising microparticles of water-insoluble substances and method for preparing same |
-
1999
- 1999-06-18 CA CA002335472A patent/CA2335472C/en not_active Expired - Fee Related
- 1999-06-18 ES ES99930387T patent/ES2194477T3/en not_active Expired - Lifetime
- 1999-06-18 WO PCT/US1999/013755 patent/WO1999065469A2/en active IP Right Grant
- 1999-06-18 DE DE69905716T patent/DE69905716T2/en not_active Expired - Lifetime
- 1999-06-18 AT AT99930387T patent/ATE233549T1/en not_active IP Right Cessation
- 1999-06-18 CN CNB998096660A patent/CN1160059C/en not_active Expired - Fee Related
- 1999-06-18 EP EP99930387A patent/EP1089714B1/en not_active Expired - Lifetime
- 1999-06-18 IL IL14027699A patent/IL140276A0/en active IP Right Grant
- 1999-06-18 KR KR1020007014477A patent/KR100622047B1/en not_active IP Right Cessation
- 1999-06-18 JP JP2000554349A patent/JP4693238B2/en not_active Expired - Fee Related
- 1999-06-18 AU AU46938/99A patent/AU755993C/en not_active Ceased
- 1999-06-18 US US09/335,735 patent/US6177103B1/en not_active Expired - Lifetime
-
2000
- 2000-12-13 IL IL140276A patent/IL140276A/en not_active IP Right Cessation
- 2000-12-14 SE SE0004620A patent/SE521255C2/en not_active IP Right Cessation
-
2002
- 2002-02-07 HK HK02100959.7A patent/HK1039566A1/en unknown
-
2003
- 2003-04-01 AU AU2003203459A patent/AU2003203459A1/en not_active Abandoned
-
2010
- 2010-11-08 JP JP2010250097A patent/JP2011079839A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3998753A (en) * | 1974-08-13 | 1976-12-21 | Hoffmann-La Roche Inc. | Water dispersible carotenoid preparations and processes thereof |
WO1995021688A1 (en) * | 1994-02-15 | 1995-08-17 | Eckhard Weidner | Process for preparing particles or powders |
WO1997014407A1 (en) * | 1995-10-17 | 1997-04-24 | Research Triangle Pharmaceuticals | Insoluble drug delivery |
WO1999052504A1 (en) * | 1998-04-09 | 1999-10-21 | F. Hoffmann-La Roche Ag | Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
Non-Patent Citations (1)
Title |
---|
G. DONSI ET AL.: "POSSIBILITY OF APPLICATION TO PHARMACEUTICAL FIELD", PHARM. ACTA HELV, 1991 - 1991, pages 170 - 173, XP002900588 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US6835396B2 (en) | 2001-09-26 | 2004-12-28 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion lyophilization |
US8722091B2 (en) | 2001-09-26 | 2014-05-13 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion lyophilization |
Also Published As
Publication number | Publication date |
---|---|
JP2011079839A (en) | 2011-04-21 |
KR100622047B1 (en) | 2006-09-07 |
WO1999065469A2 (en) | 1999-12-23 |
CA2335472C (en) | 2008-10-28 |
JP2002518318A (en) | 2002-06-25 |
AU2003203459A1 (en) | 2003-06-12 |
KR20010053041A (en) | 2001-06-25 |
ES2194477T3 (en) | 2003-11-16 |
EP1089714B1 (en) | 2003-03-05 |
SE521255C2 (en) | 2003-10-14 |
SE0004620L (en) | 2001-02-08 |
AU2003203459A8 (en) | 2010-04-29 |
AU755993C (en) | 2003-10-30 |
SE0004620D0 (en) | 2000-12-14 |
ATE233549T1 (en) | 2003-03-15 |
IL140276A0 (en) | 2002-02-10 |
HK1039566A1 (en) | 2002-05-03 |
CN1160059C (en) | 2004-08-04 |
AU4693899A (en) | 2000-01-05 |
CA2335472A1 (en) | 1999-12-23 |
IL140276A (en) | 2007-07-24 |
DE69905716T2 (en) | 2004-02-05 |
CN1312708A (en) | 2001-09-12 |
US6177103B1 (en) | 2001-01-23 |
EP1089714A2 (en) | 2001-04-11 |
DE69905716D1 (en) | 2003-04-10 |
JP4693238B2 (en) | 2011-06-01 |
AU755993B2 (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999065469A3 (en) | Processes to generate submicron particles of water-insoluble compounds | |
WO2002029139A3 (en) | Nanocrystalline aluminum metal matrix composites, and production methods | |
WO2003057367A3 (en) | Aerogel and metallic compositions | |
WO2002009669A3 (en) | Apparatus and process to produce particles having a narrow size distribution and particles made thereby | |
WO2002093132A3 (en) | Method for manufacture of fine particles | |
WO2000037167A8 (en) | A(b)n dispersants for hydrophobic particles in water-based systems | |
CA2417773A1 (en) | Expanded perlite products with controlled particle size distribution | |
AU2002212412A1 (en) | Method for making very fine particles consisting of a principle inserted in a host molecule | |
AU1374797A (en) | Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent | |
EP1160018A3 (en) | Method and apparatus for fine particle formation | |
WO2004052783A3 (en) | Soluble carbon nanotubes | |
WO2002060283A3 (en) | Food product comprising protein coated gas microbubbles | |
AU2002221596A1 (en) | Adsorbent having differently modified surface areas, method for the production thereof and use of the same | |
WO2003053561A3 (en) | A surfactant assisted nanomaterial generation process | |
AU2002303836A1 (en) | High pressure media and method of creating ultra-fine particles | |
EP1319400A3 (en) | Process to generate submicron particles of water-insoluble compounds | |
CA2391401A1 (en) | Method for the production of particles | |
WO2004043861A3 (en) | High surface area, high porosity silica packing with narrow particle and pore diameter distribution and methods of making same | |
TR200103540T2 (en) | Particle coating methods and particles produced in this way. | |
TW200503780A (en) | Composition containing drug of very low solubility and method for producing the composition | |
PT1572315E (en) | Apparatus and method for the isolation of produced particles as a suspension in a non-supercritical fluid | |
AU2001268999A1 (en) | Method for producing porous inorganic solids on the basis of an aqueous composite particle dispersion | |
AU2002233229A1 (en) | Method for producing dimensionally stable, spherical carbohydrate particles and the use thereof | |
EP1199101A3 (en) | Methods for preparing shaped sorbent | |
WO2002064234A3 (en) | Cylindrical filter cartridge with a support tube |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99809666.0 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 46938/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 140276 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 00046201 Country of ref document: SE |
|
ENP | Entry into the national phase |
Ref document number: 2335472 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2000 554349 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020007014477 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999930387 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 00046201 Country of ref document: SE |
|
WWP | Wipo information: published in national office |
Ref document number: 1999930387 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007014477 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999930387 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 46938/99 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020007014477 Country of ref document: KR |